Skip to main navigation Skip to search Skip to main content

False-positive rapid plasma reagin testing in patients with acute Plasmodium vivax malaria: A case control study

  • Ryan C. Maves
  • , Katherine Dean
  • , Nilda Gadea
  • , Eric S. Halsey
  • , Paul C.F. Graf
  • , Andres G. Lescano
  • NAMRID-Unit 3800
  • US Naval Medical Center San Diego

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Non-treponemal tests such as the rapid plasma reagin (RPR) assay are mainstays of syphilis diagnosis, but false-positive tests are common. We identified false-positive RPR titers in 8.2% of patients with malaria due to Plasmodium vivax in northern Peru. Similar rates were not detected in patients with other acute febrile illnesses.

Original languageEnglish
Pages (from-to)268-273
Number of pages6
JournalTravel Medicine and Infectious Disease
Volume12
Issue number3
DOIs
StatePublished - 2014
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Diagnostic test
  • Syphilis
  • Vivax malaria

Fingerprint

Dive into the research topics of 'False-positive rapid plasma reagin testing in patients with acute Plasmodium vivax malaria: A case control study'. Together they form a unique fingerprint.

Cite this